4/11
12:12 pm
ipa
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Low
Report
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
4/1
10:59 am
ipa
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) had its "speculative buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $3.00 price target on the stock.
Low
Report
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) had its "speculative buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $3.00 price target on the stock.
4/1
10:59 am
ipa
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) had its "speculative buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $3.00 price target on the stock.
Low
Report
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) had its "speculative buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $3.00 price target on the stock.
4/1
10:43 am
ipa
Rating for IPA
Low
Report
Rating for IPA
4/1
10:43 am
ipa
Rating for IPA
Low
Report
Rating for IPA
3/14
08:04 am
ipa
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Low
Report
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.